Muscle Oxygenation Modification During Effort in 4 Groups of Neuromuscular Diseases Compared to Healthy Controls, and Mitochondrial Function and Phenotype Assessment
Overview
- Phase
- Not Applicable
- Intervention
- muscle oxygenation
- Conditions
- Neuromuscular Diseases
- Sponsor
- University Hospital, Lille
- Enrollment
- 17
- Locations
- 3
- Primary Endpoint
- muscle oxygenation
- Status
- Completed
- Last Updated
- 10 days ago
Overview
Brief Summary
Previous studies showed modifications of muscle oxygenation parameters in muscular dystrophies du to an impairment or an absence of dystrophin.
Our study aim at assessing muscle oxygenation during effort in different neuromuscular diseases (muscular dystrophies related and not related to dystrophin, non dystrophic myopathies and motor neuron diseases) compared to a group of healthy controls. Patients and controls are invited to perform an inframaximal , standardized effort of the knee extensors by the mean of an isokinetic dynamometer. Muscle oxygenation parameters are assessed through a Near Infrared Spectroscopy (NIRS) Device.
In patients affected by dystrophin related myopathies, a muscle biopsy will be performed in order to analyse mitochondrial oxygenation parameters and mitochondrial phenotype.
Our Hypothesis is that muscle oxygenation is impaired in dystrophin related muscular dystrophies compared to other neuromuscular diseases and healthy controls because of lack of muscle capillary vessels dilatation during effort and impairment of mitochondrial function.
Detailed Description
This study is a prospective physiological study in a pathological condition (neuromuscular diseases). 5 groups of voluntary participants will be investigated: 1\. 20 subjects affected by Dystrophin related muscular dystrophy (Becker Muscular Dystrophy ) 2. Subjects affected by muscular dystrophy not related to dystrophin impairment : 20 subjects affected by facioscapulohumeral dystrophy and 20 subjects affected by Limb Girdle Muscular dystrophy 3. 20 subjects affected by non-dystrophic myopathies (Congenital myopathies ) 4. 20 subjects affected by motor diseases: amyotrophic lateral sclerosis(ALS), Charcot Marie Tooth disease, Spinal Muscular Atrophy . 5\. 20 healthy controls Objective: asses the muscular oxygenation modifications during a standardized effort and compare the variables between groups. Analyze the mitochondrial function and phenotype in the BMD group compared to healthy controls Outcome : Muscle Oxygenation by Near Infrared Spectroscopy parameters; oxygen consumption, Muscle Function Measure, Vignos and Brooke score, Borg scale, 6 minutes walk test, mitochondrial phenotype, mitochondrial oxygenation 3 visits : 1- inclusion 2- standardized effort protocol 3- for Becker dystrophy patients and voluntary controls, muscle biopsy of the Vastus Lateralis
Investigators
Eligibility Criteria
Inclusion Criteria
- •healthy subjects and
- •subjects affected by one of the fallowing neuromuscular diseases: Becker Muscular dystrophy Facioscapulohumeral dystrophy, Limb Girdle Muscular Dystrophy , Congenital Myopathy , Spinal Muscular Atrophy Charcot Marie Tooth Disease and Amyotrophic Lateral Sclerosis ,
- •able to walk
- •presenting a manual muscle testing of at Least 4/5 on the quadriceps according to the Medical research Council
Exclusion Criteria
- •musculoskeletal pain of the quadriceps
- •other neurological disorders
- •Heart failure arrhythmia, uncontrolled hypertension, angina pectoris
- •dyspnoea \>2 according to the NYHA
- •Peripheral artery disease
- •BMI \>30kg.m-2.
Arms & Interventions
muscle oxygenation
assesment of muscle oxygenation and gas exchanges
Intervention: muscle oxygenation
Outcomes
Primary Outcomes
muscle oxygenation
Time Frame: on the day of first evaluation Visit V1
level of deoxyhemoglobin assessed with the NIRS device during the isokinetic effort of the knee extensors
Muscle oxygenation
Time Frame: on the day of first evaluation Visit V1
kinetics of the deoxyhemoglobin assessed with the NIRS device during the isokinetic effort of the knee extensors
Secondary Outcomes
- Gas exchange(on the day of first evaluation Visit V1)
- MFM score(on the day of first evaluation Visit V1)
- 6 Minutes Walking Test (MWT)(on the day of first evaluation Visit V1)
- Mitochondrial H2O2 production(at V2 at least 1 week after V1)
- Vignos functional scales(on the day of first evaluation Visit V1)
- maximal isokinetic strength of the knee extensors(on the day of first evaluation Visit V1)
- Brooke functional scales(on the day of first evaluation Visit V1)
- Medical Research Council Muscle testing(on the day of first evaluation Visit V1)
- Mitochondrial phenotype(at V2 at least 1 week after V1)
- kinetic of Muscle oxygenation(on the day of first evaluation Visit V1)